- Advertisement -

AI-based technology accelerates discovery of new tuberculosis drug candidates

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and into the lungs,...

Purdue Joins Biomanufacturing Program Designed for Students and Industry Professionals

Major Indiana life science players agreed to elevate the state’s biomanufacturing workforce at the annual BioCrossroads Life Sciences Summit. Leaders from BioCrossroads, Purdue University,...

Finding the best targets to improve crop yield by following CO2 journey inside the leaf

Credit: Natalia Bateman, CoETP A team of scientists have measured the relative importance of the different obstacles...

Single-cell proteomic analysis uncovers hidden layers of blood cell formation

In the past decade there has been significant interest in studying the expression of our genetic code down to the level of single cells,...

Bring Greater Efficiency to Your Biobank Lab

/* custom css */ .td_uid_1_5d726d114b192_rand { min-height: 0; } /* custom css */ .td_uid_2_5d726d114b506_rand { vertical-align: baseline; } REGISTER NOW jQuery(window).load(function () { jQuery('body').find('#td_uid_1_5d726d114b18a .td-element-style').each(function...

Nanollose non-executive director demonstrates confidence in biotechnology strategy with on-market purchase...

Nanollose Ltd (ASX:NC6) non-executive director Winton Willesee has demonstrated confidence in the company’s biotechnology strategy utilising tree-free fibres with the purchase of shares in...

The Emerging Power of Mass Spectrometry in Oncology

Globally, the incidence of newly diagnosed cancer cases is projected to increase over the next decade.1 Despite advancements in personalized medicine and therapeutic options,...

Novartis Shares Slide After Neuromuscular Candidate Acquired with Avidity Fails Phase...

Novartis shares fell the most in a single day since the COVID-19 pandemic after the pharma giant acknowledged that its neuromuscular candidate delpacibart etedesiran...

The Emerging Power of Mass Spectrometry in Oncology

Globally, the incidence of newly diagnosed cancer cases is projected to increase over the next decade.1 Despite advancements in personalized medicine and therapeutic options,...

Novartis Shares Slide After Neuromuscular Candidate Acquired with Avidity Fails Phase III Trial

Novartis shares fell the most in a single day since the COVID-19 pandemic after the pharma giant acknowledged that its neuromuscular candidate delpacibart etedesiran...

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne Gene Therapy

Switzerland-headquartered NewBiologix signed an agreement with Synastra Biotechnology to develop a stable producer cell line for Synastra’s investigational Duchenne muscular dystrophy (DMD) gene therapy...

more new items

The Emerging Power of Mass Spectrometry in Oncology

Globally, the incidence of newly diagnosed cancer cases is projected to increase over the next decade.1 Despite advancements in personalized medicine and therapeutic options,...

Novartis Shares Slide After Neuromuscular Candidate Acquired with Avidity Fails Phase...

Novartis shares fell the most in a single day since the COVID-19 pandemic after the pharma giant acknowledged that its neuromuscular candidate delpacibart etedesiran...

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne...

Switzerland-headquartered NewBiologix signed an agreement with Synastra Biotechnology to develop a stable producer cell line for Synastra’s investigational Duchenne muscular dystrophy (DMD) gene therapy...